Skip to content

KIDS · NASDAQ

OrthoPediatrics (KIDS) Stock Price & Fundamentals

$1,271.74+0.34%+$4.35End-of-day price as of Oct 9, 2026

OrthoPediatrics (KIDS) closed at $1,271.74 on Oct 9, 2026, up 0.34% from the previous close of $1,267.39.

Share price, past year

1Y +17.10%

52-week range $1,007.70 – $1,284.70. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$1,271.74
Sep 30, 2026$1,236.55
Aug 31, 2026$1,192.89
Jul 31, 2026$1,170.95
Jun 30, 2026$1,186.02
May 29, 2026$1,104.32
Apr 30, 2026$1,032.44
Mar 31, 2026$1,072.47
Feb 27, 2026$1,060.59
Jan 30, 2026$1,079.37
Dec 31, 2025$1,138.42
Nov 28, 2025$1,113.77
Oct 31, 2025$1,073.36

Key statistics

Market cap
$31.91B
P/E (TTM)
—
EPS (TTM)
−$1.68
Revenue (TTM)
$252.73M
Net income (TTM)
−$39.73M
Shares outstanding
25.1M
Dividend yield
—
52-week range
$1,007.70 – $1,284.70

OrthoPediatrics's market cap is $31.91B, based on a share price of $1,271.74 and 25.1M shares outstanding as of Dec 31, 2025.

Financials

OrthoPediatrics reported revenue of $236.35M for fiscal 2025, up 15.45% from fiscal 2024.

OrthoPediatrics reported a net loss of $39.65M in fiscal 2025.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
OrthoPediatrics annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$236.35M+15.5%−$39.65M−16.8%−$1.69−$15.96M
FY2024ended Dec 31, 2024$204.73M+37.7%−$37.82M−18.5%−$1.64−$41.31M
FY2023ended Dec 31, 2023$148.73M+21.6%−$20.97M−14.1%−$0.92−$43.92M
FY2022ended Dec 31, 2022$122.29M+24.7%$1.26M1.0%$0.06−$31.80M
FY2021ended Dec 31, 2021$98.05M+38.0%−$16.26M−16.6%−$0.84−$21.17M
FY2020ended Dec 31, 2020$71.08M−2.0%−$32.94M−46.4%−$1.82−$29.03M
FY2019ended Dec 31, 2019$72.55M+26.1%−$13.73M−18.9%−$0.94−$29.59M
FY2018ended Dec 31, 2018$57.56M+26.2%−$12.03M−20.9%−$0.96−$20.84M
FY2017ended Dec 31, 2017$45.62M+22.3%−$8.93M−19.6%−$5.86−$12.42M
FY2016ended Dec 31, 2016$37.30M—−$6.57M−17.6%−$7.14−$5.47M
OrthoPediatrics quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$70.51M−$7.16M−$0.30
Q1 FY2026ended Mar 31, 2026$59.36M−$10.69M−$0.45
Q4 FY2025ended Dec 31, 2025$61.61M−$10.10M−$0.43
Q3 FY2025ended Sep 30, 2025$61.25M−$11.77M−$0.50
Q2 FY2025ended Jun 30, 2025$61.08M−$7.11M−$0.30
Q1 FY2025ended Mar 31, 2025$52.41M−$10.66M−$0.46
Q4 FY2024ended Dec 31, 2024$52.67M−$16.07M−$0.70
Q3 FY2024ended Sep 30, 2024$54.57M−$7.92M−$0.34

Company profile

Name
OrthoPediatrics Corp.
Ticker
KIDS
Exchange
NASDAQ
Industry (SEC SIC)
Surgical & Medical Instruments & Apparatus
Headquarters
2850 Frontier Drive, Warsaw, IN 46582
Fiscal year ends
December
SEC CIK
0001425450

Recent SEC filings

Frequently asked questions

What is OrthoPediatrics's stock price?

OrthoPediatrics (KIDS) closed at $1,271.74 on Oct 9, 2026, up 0.34% from the previous close of $1,267.39.

What is OrthoPediatrics's market cap?

OrthoPediatrics's market cap is $31.91B, based on a share price of $1,271.74 and 25.1M shares outstanding as of Dec 31, 2025.

How much revenue does OrthoPediatrics make?

OrthoPediatrics reported revenue of $236.35M for fiscal 2025, up 15.45% from fiscal 2024.

Does OrthoPediatrics pay a dividend?

OrthoPediatrics's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from OrthoPediatrics Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures